Nelarabine recalls
Nelarabine products have been recalled 2 times, most recently on 12 Mar 2025. The recalling company is usually Zydus Pharmaceuticals (USA). The most common reason is potency & assay.
Total recalls2since 2025
Last 12 months0reported
Class I00% of total
Ongoing2latest 12 Mar 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why nelarabine is recalled
Companies
Product types
By year
Ongoing nelarabine recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nelarabine Injection, 250mg/, (5mg/mL) recalledNelarabine | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
| Drug | CLASS II | Nelarabine Injection, 250mg/, (5mg/mL) recalledNelarabine | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
All nelarabine recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nelarabine Injection, 250mg/, (5mg/mL) recalledNelarabine | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
| Drug | CLASS II | Nelarabine Injection, 250mg/, (5mg/mL) recalledNelarabine | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.